secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOLASE, INC (—)
CIK:        0000811240
Form:       8-K
Filed at:   2023-08-15T23:59:59+00:00
Accession:  0001193125-23-212769
Event type: regulatory
Sentiment:  positive
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

BIOLASE avoids Nasdaq delisting but faces one-year Mandatory Panel Monitor for bid price compliance
--------------------------------------------------------------------------------

- Nasdaq Hearings Panel confirmed BIOLASE currently complies with continued listing requirements.
- Company subject to a one-year Mandatory Panel Monitor starting August 14, 2023.
- If bid price rule violated during monitor, no cure period allowed; staff issues delist determination.
- Company can request a new hearing if delist determination is issued.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/811240/000119312523212769/0001193125-23-212769-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/811240/000119312523212769/d521897d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-212769

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer